Diagnostic accuracy of 89Zr-rituximab-PET/CT imaging in patients with relapsed CD20+B-Cell non-Hodgkin's lymphoma: comparison with 18FDG-PET/CT.

被引：0
|
作者：
Muylle, K. [1 ]
Vugts, D. J. [2 ]
Meuleman, N. [1 ]
Ghanem, G. [1 ]
Bourgeois, P. [1 ]
Vanderlinden, B. [1 ]
Van Dongen, G. A. M. S. [2 ]
Bron, D. [1 ]
Flamen, P. [1 ]
机构：
[1] ULB, Inst Jules Bordet, Brussels, Belgium
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP424
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] Demonstration of peripheral nerve root involvement by non-Hodgkin’s lymphoma on 18F-FDG PET/CT
    Henry Guo
    Camila Mosci
    Andrei Iagaru
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 729 - 730
  • [42] Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by 18F-FDG PET/CT
    Mapelli, P.
    Vanoli, E. G.
    Picchio, M.
    Gianolli, L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (02): : 125 - 125
  • [43] Combination of FDG PET/CT radiomics and clinical parameters for outcome prediction in patients with non-Hodgkin's lymphoma
    Ortega, Claudia
    Anconina, Reut
    Joshi, Sayali
    Metser, Ur
    Prica, Anca
    Johnson, Sarah
    Liu, Zhihui Amy
    Keshavarzi, Sareh
    Veit-Haibach, Patrick
    NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (12) : 1039 - 1046
  • [44] Staging and Indices measured with 18F-FDG PET/CT as a predictor of survival in Non-hodgkin's lymphoma
    Serim, B. Dirlik
    Umit, E.
    Ustun, F.
    Tokuc, B.
    Demir, M.
    Altun, G. Durmus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S691 - S691
  • [45] Texture Indices of 18F-FDG PET/CT for Differentiating Squamous Cell Carcinoma and Non-Hodgkin's Lymphoma of the Oropharynx
    Mitamura, Katsuya
    Norikane, Takashi
    Yamamoto, Yuka
    Ihara-Nishishita, Ayumi
    Kobata, Takuya
    Fujimoto, Kengo
    Takami, Yasukage
    Kudomi, Nobuyuki
    Hoshikawa, Hiroshi
    Nishiyama, Yoshihiro
    ACTA MEDICA OKAYAMA, 2021, 75 (03) : 351 - 356
  • [46] Rituximab maintenance therapy after autologous stem cell transplantation in patients with CD20+B-cell non-Hodgkin lymphoma - Feasibility
    Neumann, F
    Harmsen, S
    Martin, S
    Kronenwett, R
    Kondakci, M
    Fenk, R
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S8 - S8
  • [47] Prognostic value of semiquantitative analysis of interim 18F-FDG PET/CT in patients with non-Hodgkin's lymphoma.
    Henzlova, Lenka
    Kapitanova, Zuzana
    Koranda, Pavel
    Myslivecek, Miroslav
    Papajik, Tomas
    Buriankova, Eva
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [48] FDG PET/CT Response Assessment Criteria for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma at End of Therapy: A Multiparametric Approach
    Metser U.
    Mohan R.
    Beckley V.
    Moshonov H.
    Hodgson D.
    Murphy G.
    Nuclear Medicine and Molecular Imaging, 2016, 50 (1) : 46 - 53
  • [49] Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al. (2009)
    Larry R. White
    Molecular Imaging and Biology, 2012, 14 : 397 - 398
  • [50] Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al. (2009)
    White, Larry R.
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (04) : 397 - 398
12345